Dual VEGF/PDGF-B-Targeting SOMAmers (SomaLogic)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDual VEGF/PDGF-B-Targeting SOMAmers (SomaLogic)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsPlatelet-derived growth factor subunit B inhibitors
TargetsPlatelet-derived growth factor subunit BVascular endothelial growth factor receptor
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSomalogic Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSomalogic Inc
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A